{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "SARS-CoV-2",
      "United States",
      "correctional facilities",
      "incarcerated persons",
      "prisons",
      "respiratory infections",
      "severe acute respiratory syndrome coronavirus 2",
      "vaccine effectiveness",
      "viruses",
      "zoonoses"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "35731137",
  "DateCompleted": {
    "Year": "2022",
    "Month": "06",
    "Day": "24"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "07",
    "Day": "16"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.3201/eid2807.220091"
    ],
    "Journal": {
      "ISSN": "1080-6059",
      "JournalIssue": {
        "Volume": "28",
        "Issue": "7",
        "PubDate": {
          "Year": "2022",
          "Month": "Jul"
        }
      },
      "Title": "Emerging infectious diseases",
      "ISOAbbreviation": "Emerg Infect Dis"
    },
    "ArticleTitle": "Vaccine Effectiveness during Outbreak of COVID-19 Alpha (B.1.1.7) Variant in Men's Correctional Facility, United States.",
    "Pagination": {
      "StartPage": "1313",
      "EndPage": "1320",
      "MedlinePgn": "1313-1320"
    },
    "Abstract": {
      "AbstractText": [
        "In April 2021, a COVID-19 outbreak occurred at a correctional facility in rural Virginia, USA. Eighty-four infections were identified among 854 incarcerated persons by facilitywide testing with reverse transcription quantitative PCR (qRT-PCR). We used whole-genome sequencing to link all infections to 2 employees infected with the B.1.1.7\u03b1 (UK) variant. The relative risk comparing unvaccinated to fully vaccinated persons (mRNA-1273 [Moderna, https://www.modernatx.com]) was 7.8 (95% CI\u00a04.8-12.7), corresponding to a vaccine effectiveness of 87.1% (95% CI\u00a079.0%-92.1%). Average qRT-PCR cycle threshold values were lower, suggesting higher viral loads, among unvaccinated infected than vaccinated cases for the nucleocapsid, envelope, and spike genes. Vaccination was highly effective at preventing SARS-CoV-2 infection in this high-risk setting. This approach can be applied to similar settings to estimate vaccine effectiveness as variants emerge to guide public health strategies during the ongoing pandemic."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Silverman",
        "ForeName": "Rachel A",
        "Initials": "RA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Ceci",
        "ForeName": "Alessandro",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Cohen",
        "ForeName": "Alasdair",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Helmick",
        "ForeName": "Meagan",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Short",
        "ForeName": "Erica",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Bordwine",
        "ForeName": "Paige",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Friedlander",
        "ForeName": "Michael J",
        "Initials": "MJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Finkielstein",
        "ForeName": "Carla V",
        "Initials": "CV"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Emerg Infect Dis",
    "NlmUniqueID": "9508155",
    "ISSNLinking": "1080-6040"
  },
  "SupplMeshList": [
    "SARS-CoV-2 variants"
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "epidemiology",
        "prevention & control"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Correctional Facilities"
    },
    {
      "QualifierName": [
        "prevention & control"
      ],
      "DescriptorName": "Disease Outbreaks"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "United States"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Vaccine Efficacy"
    }
  ]
}